Glenn Sblendorio
Director Ejecutivo en IVERIC BIO, INC. .
Fortuna: 850 171 $ al 30/04/2024
Origen de la red de primer grado Glenn Sblendorio.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 59 | |
| Subsidiary | Pharmaceuticals: Major | 58 | |
Pace University
56
| College/University | Other Consumer Services | 56 |
| Public Company | Pharmaceuticals: Major | 48 | |
Fairleigh Dickinson University
41
| College/University | Other Consumer Services | 41 |
| Subsidiary | Pharmaceuticals: Generic | 41 | |
| Public Company | Biotechnology | 11 | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York.
9
| Subsidiary | Biotechnology | 9 |
Sony Interactive Entertainment LLC
 Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Sony Interactive Entertainment LLC develops game software. The company was founded on April 1, 2016 and is headquartered in San Mateo, CA.
1
| Subsidiary | Packaged Software | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Glenn Sblendorio a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Doctorate Degree Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Corporate Officer/Principal Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Sales & Marketing General Counsel Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Portfolio Manager-Equities Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Comptroller/Controller/Auditor Corporate Officer/Principal | |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Secretary Compliance Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Chairman Chief Executive Officer Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor Private Equity Investor | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer Director/Board Member | |
Eyebiotech Ltd.
 Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Orthovita, Inc.
 Orthovita, Inc. Medical SpecialtiesHealth Technology Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Stack Pharmaceuticals, Inc.
 Stack Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Stack Pharmaceuticals, Inc. provides consulting services. The private company is based in Troy Hills, NJ. The company was founded by David M. Stack. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chairman Chief Executive Officer | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 44 |
| Italia | 3 |
| Francia | 2 |
| Israel | 2 |
| Irlanda | 2 |
Sectorial
| Health Technology | 35 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
Operativa
| Director/Board Member | 700 |
| Corporate Officer/Principal | 229 |
| Independent Dir/Board Member | 222 |
| Chairman | 132 |
| Undergraduate Degree | 83 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| James Topper | 49 |
| Daniel Bradbury | 45 |
| Michael Ross | 44 |
| Jonathan Silverstein | 42 |
| Nicholas G. Galakatos | 38 |
| Adrienne Graves | 38 |
| William W. Crouse | 29 |
| Bruce Peacock | 28 |
| David Guyer | 27 |
| David Stack | 27 |
| Gino Santini | 26 |
| Thomas Dyrberg | 24 |
| Daniel Welch | 24 |
| Robert Hugin | 24 |
- Bolsa de valores
- Insiders
- Glenn Sblendorio
- Conexiones Empresas
